The only issue here is FDA approval. With approval in the bag, the floor is laid and we only go up as the procedure gains traction. With approval, CTUM will perservere through years of market upswings and downturns.
As for the other alternative, after Chastang, I don't want to consider it LOL. Seriously, I really believe that Frank wouldn't have taken on the role he did unless he was confident he could successfully apply to the FDA.
Russia, the Ukraine.....yes the approval process and the standards are different, but DR was wise to test the waters in Moscow first and await that result before submitting here. He's been very deliberate about applying, much to our occasioanl frustration, but I feel comfortable that no rock has been left unturned in his quest for the FDA blessing.
News 
Market Data 
Discover 
AI
